Drugs / Peg-ASP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03154918 | Jun 2017 → Dec 2020 | extranodal nasal NK/T cell lymphoma | Sichuan University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Peg-ASP | “Peg-ASP 2500 U/m 2 days 4” NCT03154918 ↗ |